Aura Biosciences Statistics Share Statistics Aura Biosciences has 62.12M
shares outstanding. The number of shares has increased by 24.99%
in one year.
Shares Outstanding 62.12M Shares Change (YoY) 24.99% Shares Change (QoQ) 23.45% Owned by Institutions (%) 65.7% Shares Floating 41.55M Failed to Deliver (FTD) Shares 514 FTD / Avg. Volume 0.29%
Short Selling Information The latest short interest is 2.79M, so 4.5% of the outstanding
shares have been sold short.
Short Interest 2.79M Short % of Shares Out 4.5% Short % of Float 5.12% Short Ratio (days to cover) 19.26
Valuation Ratios The PE ratio is -4.7 and the forward
PE ratio is -3.29.
Aura Biosciences's PEG ratio is
0.5.
PE Ratio -4.7 Forward PE -3.29 PS Ratio 0 Forward PS 20 PB Ratio 2.69 P/FCF Ratio -5.03 PEG Ratio 0.5
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Aura Biosciences.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 10.77,
with a Debt / Equity ratio of 0.12.
Current Ratio 10.77 Quick Ratio 10.77 Debt / Equity 0.12 Debt / EBITDA -0.22 Debt / FCF -0.23 Interest Coverage 0
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee n/a Profits Per Employee $-819.99K Employee Count 106 Asset Turnover 0 Inventory Turnover n/a
Taxes Income Tax 112K Effective Tax Rate -0.13%
Stock Price Statistics The stock price has increased by -38.63% in the
last 52 weeks. The beta is 0.45, so Aura Biosciences's
price volatility has been higher than the market average.
Beta 0.45 52-Week Price Change -38.63% 50-Day Moving Average 6.65 200-Day Moving Average 6.94 Relative Strength Index (RSI) 53.88 Average Volume (20 Days) 179,775
Income Statement
Revenue n/a Gross Profit -1.22M Operating Income -96.12M Net Income -86.92M EBITDA -85.58M EBIT -86.81M Earnings Per Share (EPS) -1.75
Full Income Statement Balance Sheet The company has 31.69M in cash and 18.77M in
debt, giving a net cash position of 12.92M.
Cash & Cash Equivalents 31.69M Total Debt 18.77M Net Cash 12.92M Retained Earnings -374.23M Total Assets 204.4M Working Capital 169.11M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -79.81M
and capital expenditures -1.25M, giving a free cash flow of -81.06M.
Operating Cash Flow -79.81M Capital Expenditures -1.25M Free Cash Flow -81.06M FCF Per Share -1.63
Full Cash Flow Statement Margins
Gross Margin n/a Operating Margin n/a Pretax Margin n/a Profit Margin n/a EBITDA Margin n/a EBIT Margin n/a FCF Margin n/a
